Selected Publication:  

 

1. Liu, X.; Cao, R.; Wang, S.; Jia, J.; Fei, H.*, Amphipathicity determines different cytotoxic mechanisms of lysine- or arginine-rich cationic hydrophobic peptides in cancer cells. Journal of Medicinal Chemistry, 2016. 

 

2. Wang, Q.; Ma, X.; Jia, J.; Fei, H.*, A peptide–lipid nanoparticle assembly platform with integrated functions for targeted cell delivery. Journal of Materials Chemistry B, 2016, 4. 

 

3. Ma, X.; Jia, J.; Cao, R.; Wang, X.; Fei, H.*, Histidine–Iridium(III) Coordination-Based Peptide Luminogenic Cyclization and       Cyclo-RGD Peptides for Cancer-Cell Targeting. JACS 2014, 136 (51), 17734-17737.

 

4. Ma, X.; Wang, X.; Zhou, M.; Fei, H.*, A mitochondria-targeting gold-Peptide nanoassembly for enhanced cancer-cell killing. Adv Healthc Mater 2013, 2 (12), 1638-43. 

 

5. Cao R, Jia J, Ma X, Zhou M, Fei H*. Membrane Localized Iridium(III)  Complex  Induces  Endoplasmic  Reticulum Stress and Mitochondria Mediated Apoptosis in Human Cancer Cells. J Med Chem. 2013 May 9;56(9):3636-44. 

 

6.Wang X, Jia J, Huang Z, Zhou M, Fei H*. Luminescent Peptide Labeling based on a Histidine binding Iridium(III) Complex for Cell Penetration and Intracellular Targeting Studies. Chem. Eur. J., 2011 Jul 11;17(29):8028-32.

 

7. Fei H, Grygoruk A, Brooks ES, Chen A, Krantz DE. Trafficking of vesicular neurotransmitter transporters. Traffic. 2008 Sep;9(9):1425-36.

 

8. Fei H, Karnezis T, Reimer RJ, Krantz DE: Membrane topology of Drosophila vesicular glutamate transporter. J. Neurochem. 2007 Jun;101(6):1662-71.

 

9. Scott GK, Fei H, Thomas L, Megideshi G, Thomas G: PACS-1, GGA3 and CK2 cooperate to control CI-MPR trafficking. EMBO J. 2006 Oct 4;25(19):4423-35.

 

10. Fei H, Luo MJ, Ye YZ, Ding DF, Chi CW: The Inhibitory Activities of Recombinant Eglin C Mutants on Kexin and Furin, Using Site-directed Mutagenesis and Molecular Modeling.  Acta Biochimica et Biophysica Sinica. 2001; 33(6):591-599.

 

Last changed: June 24, 2016